Loading organizations...
Nissay Capital operates as a corporate venture capital arm, strategically investing in emerging companies across various stages of development. Based in Tokyo, the firm provides capital to ventures within high-growth sectors, including information technology, manufacturing, and medical industries. Its approach focuses on identifying and nurturing innovative businesses, integrating them into a broader ecosystem through its corporate backing.
The firm was established in 1991 as an initiative by Nippon Life Insurance, a prominent Japanese insurer. This founding reflected a strategic insight to participate directly in the innovation economy, leveraging the parent company's robust financial foundation to support the growth of nascent enterprises. Nissay Capital's formation allowed Nippon Life to extend its financial expertise into venture investing, fostering new technologies and business models.
Nissay Capital primarily serves early to mid-stage startups seeking growth capital and strategic guidance. The firm's long-term vision is to contribute to industrial development and innovation by identifying and backing companies that demonstrate significant potential. It aims to build a diversified portfolio of promising ventures, ultimately fostering new industries and supporting economic advancement.
Key people at Nissay Capital.
Nissay Capital is the venture capital arm of Nippon Life Insurance Company, Japan's largest life insurer, focusing on early and growth-stage investments across diverse sectors.[1][3][5] Established to build a balanced portfolio, it targets seed through later-stage opportunities in areas like financial services, technology, media, telecom (TMT), healthcare, software, internet, e-commerce, and information technology, with over 1,200 investments and 226-271 portfolio exits, including 27 documented IPOs or similar outcomes.[1][3][5] Its mission aligns with long-term value creation for Nippon Life, emphasizing multi-sector diversification and sustained growth in unlisted companies, while contributing to Japan's startup ecosystem through capital, networks, and co-investments with firms like Global Brain and SBI Investment.[3]
Nissay Capital was founded in 1991 as a corporate venture capital entity wholly owned by Nippon Life Insurance Company, based in Tokyo, Japan.[1][3][5] Key details on founding partners are not specified in available data, but its evolution reflects a shift toward a broad, balanced investment approach, starting with early unlisted company bets and expanding to over 1,200 investments by supporting growth across stages and sectors.[1][3] Pivotal moments include achieving 226 IPOs since inception and recent activity like a $8.06M Series B in May 2025, demonstrating consistent ecosystem engagement.[1][3]
Nissay Capital rides Japan's maturing VC ecosystem, fueled by trends in fintech, TMT, healthcare, and software amid digital transformation and an aging population.[1][3][5] Its timing benefits from post-1990s economic recovery, government startup initiatives, and Nippon Life's stable capital, allowing contrarian bets on unlisted firms during market inefficiencies.[1][4] Market forces like rising IPO activity (226 achieved) and co-investment synergies amplify its influence, fostering ecosystem growth by bridging corporate capital with innovative startups in crowdsourcing, SaaS, and e-commerce.[3][5]
Nissay Capital's trajectory points to sustained activity in high-growth Japanese tech, with recent 2025 deals signaling momentum in Series B and beyond.[3] Trends like AI integration in healthcare/software and fintech expansion will shape its path, potentially increasing exits amid Japan's VC rebound. Its corporate VC model may evolve toward deeper operating support, amplifying influence in Asia's startup landscape and reinforcing its role as a steady ecosystem anchor.[1][3][5]
Key people at Nissay Capital.
Nissay Capital has 21 tracked investments across 19 companies. The latest tracked deal is $11.1M Series A in CommerceX Holdings in February 2026.
